MedPath

Ozmosis Research, Inc.

Ozmosis Research, Inc. logo
🇨🇦Canada
Ownership
Private
Employees
11
Market Cap
-
Website
https://ozmosisresearch.ca

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer

Phase 2
Completed
Conditions
Metastatic Breast Cancer
Interventions
Drug: Placebo
First Posted Date
2011-03-08
Last Posted Date
2021-04-14
Lead Sponsor
Ozmosis Research Inc.
Target Recruit Count
40
Registration Number
NCT01310231
Locations
🇨🇦

London Regional Cancer Program, London, Ontario, Canada

🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.